Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-441-9 | CAS number: 106-91-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Mode of action of the chemical, toxicokinetics and metabolism
Limited toxicokinetic and metabolism data are available for GMA. The metabolism of glycidyl methacrylate in mammals is hypothesized to proceed by at least two different and competing enzyme systems, epoxide hydratase and non-specific carboxylesterases. Metabolism of GMA by carboxylesterase would result in formation of glycidol and methacrylic acid as metabolites, while initial metabolism by epoxide hydrolase would result in the formation of glycerol methacrylate. The relative speed at which the two competing metabolic reactions occur in different tissues and species is likely to be important for understanding the toxicity of glycidyl methacrylate.
Species differences in the activity of these enzymes suggest that the carboxylesterase route of metabolism may predominate in the nasal tissue of rabbits (yielding glycidol and methacrylic acid) whereas the epoxide hydratase route would likely predominate in rats and humans (producing glycerol methacrylate, then glycerol and methacrylic acid by carboxylesterase).(Bogdanffy et al.: 1987, Dahl et al.: 1987, Glatt et al.: 1984, Mattes and Mattes: 1992, Pacifici et al.: 1981).
Toxicokinetics of glycidyl methacrylate were investigated in rabbits. After an intravenous injection at 200 mg/kg, over 95 % of the parent compound disappeared from the blood within 10 minutes according to a two-compartment open model. Following a subcutaneous injection at 800 mg/kg, the toxicokinetics appeared to fit a first-order absorption one-compartment open model. This chemical was metabolized by incubation with whole blood, plasma, erythrocyte suspension, and homogenates of various tissues. The subcutaneous co-administration of tri-o-cresyl-phosphate (a carboxylesterase inhibitor) with this chemical resulted in about a ten-fold increase in the maximum blood concentrations, compared to those of animals dosed with this chemical alone. (Shi Tao et al.: 1988). This finding suggests a key role of carboxylesterase in glycidyl methacrylate metabolism and although metabolites were not specifically measured, could implicate glycidol as that metabolite.
More definitive work on the metabolism of glycidyl methacrylate (GMA) was studied by Domoradzki et al. (2004)in vitro using liver homogenate and nasal epithelial tissues from humans, rats and rabbits. Radiolabeled GMA [14C 1,3- glycidyl] was used in this study and was 92% radio chemically pure. In vitro incubations of14C GMA with tissue preparations from human, rat and rabbit resulted in the formation of only one metabolite. This metabolite was tentatively identified as glycidol based on retention time match with14C-glycidol. At an initial starting concentration of GMA at 2 mM, half-lives of GMA hydrolysis were faster in incubations with rat and rabbit tissue. Although the biotransformation was faster in rats and rabbits as compared to humans (completed within 30 minutes versus 2 hours), under all circumstances only one metabolite appeared which was tentatively identified as glycidol (EINECS 209 -128 -3).
Results indicate that glycidyl methacrylate is rapidly metabolized in vivo in rabbits as measured by disappearance of parent material (95% of intravenous administered dose of 200 mg/kg eliminated within 10 minutes). Maximum blood levels of GMA were increased by 10 fold in rabbits co-administered a carboxylesterase inhibitor indicating that glycidyl methacrylate was likely metabolized by carboxylesterase to glycidol and methacrylic acid. Domoradzki observed similar findings in rat and rabbit liver and respiratory tract epithelium cell fractions in vitro. Gycidol was identified as the metabolite of glycidyl methacrylate in this study.
Metabolism of GMA to glycidol has ramifications for hazard identification. Glycidol has a harmonised classification according to REACH and CLP as carcinogenic (category 1B), germ cell mutagenic (category 2) and toxic to reproduction (category 1B).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.